State Ledger
Company profile

Caris Life Sciences, Inc. CIK 2019410

Ticker
CAI (Nasdaq)
Industry
Services-Medical Laboratories
Headquarters
Irving, TX 75039
Fiscal year end
2025 (FY)
Market Data
Close
$29.70
Change
+$0.04
Change %
0.13%
Volume
229,459

CAI · trading date Oct 12, 2026 · previous close $29.66 · source: Alpaca (IEX feed, not consolidated full-market data).

Key Financials
Revenue
$812.03M
Net income
-$68.09M
Total assets
$1.13B
Total liabilities
$548.36M
Stockholders' equity
$577.31M
Cash & equivalents
$796.27M
Operating income
$45.11M
Operating cash flow
$83.16M
Capital expenditures
$16.26M

Fiscal year 2025, via 10-K filed 2026-03-03. A dash means this figure wasn't reported in the source filing under a field State Ledger recognizes - not that the value is zero.

Financial Performance
Operating margin
5.6%
Net margin
-8.4%
Free cash flow
$66.90M
Free cash flow margin
8.2%
Liabilities / assets
48.7%
Equity / assets
51.3%
CapEx / revenue
2.0%
Operating cash flow / net income
-1.22×

Derived from the fiscal year 2025 figures above. These metrics are mathematical calculations and do not represent a rating or assessment of the company.

Financial History
Fiscal yearRevenueNet incomeAssetsLiabilitiesEquity
2025 $812.03M -$68.09M $1.13B $548.36M $577.31M
2024 $412.26M -$281.89M $343.73M $620.92M -$2.50B
2023 $306.13M -$341.42M — — -$2.14B
Company Details
SIC code
8071
State of incorporation
TX
Active filer
Yes
Most recent SEC filing
Form 4
2026-09-17
Financials filed via
Form 10-K
filed 2026-03-03

"Most recent SEC filing" may differ from the filing used for the financial figures above.

Location
Irving, TX 75039
750 W JOHN CARPENTER FREEWAY
Data & Methodology

SEC EDGAR submissions API (identity, collected Sep 19, 2026, 15:11 UTC) and SEC XBRL Company Facts API (financials, collected Sep 26, 2026, 15:58 UTC) · figures as originally filed, not restated · a dash always means a value wasn't reported, never a real zero.

← Back to Texas — Public Companies